Read More Pharma Industry News Aligos Therapeutics stops development of CHB drug candidate ALG-010133 Aligos Therapeutics has stopped further development of ALG-010133, its STOPS drug candidate, in chronic hepatitis B (CHB) owing… bySrinathJanuary 8, 2022
